-
EP1424997
European procedure
Extract from the Register of European Patents
EP About this file: EP1424997
| EP1424997 - AMINO ACID MODULATED EXTENDED RELEASE DOSAGE FORM [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 26.09.2008 Database last updated on 14.11.2024 | Most recent event Tooltip | 26.09.2008 | No opposition filed within time limit | published on 29.10.2008 [2008/44] | Applicant(s) | For all designated states SCOLR, Inc. 8340 154th Avenue, N.E. Redmond, WA 98052 / US | [2004/24] | Inventor(s) | 01 /
FASSIHI, A., Reza 2 Lee Road Ambler, PA 19002 / US | 02 /
DURIG, Thomas 5 Concord Way Chadds Ford, PA 19317 / US | [2007/47] |
| Former [2004/37] | 01 /
FASSIHI, A., Reza 2 Lee Road Ambler, PA 19002 / US | ||
| 02 /
DURIG, Thomas 5 Concord Way Chads Ford, PA 19317 / US | |||
| Former [2004/24] | 01 /
FASSIHI, A., Reza 2 Lee Road Ambler, PA 19002 / US | ||
| 02 /
DURIG, Thomas 1109 Charleston Greene Malvern, PA 19355 / US | Representative(s) | SSM Sandmair Patentanwälte Rechtsanwalt Partnerschaft mbB Joseph-Wild-Straße 20 81829 München / DE | [N/P] |
| Former [2006/12] | Schwabe - Sandmair - Marx Patentanwälte P.O. Box 86 02 45 81629 München / DE | ||
| Former [2004/24] | Teipel, Susanne, Dr., et al Schwabe, Sandmair, Marx Patentanwälte Stuntzstrasse 16 81677 München / DE | Application number, filing date | 02706380.9 | 20.02.2002 | [2004/24] | WO2002US05416 | Priority number, date | WO2001US42156 | 14.09.2001 Original published format: PCT/US01/42156 | US20010997377 | 30.11.2001 Original published format: US 997377 | [2004/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03024428 | Date: | 27.03.2003 | Language: | EN | [2003/13] | Type: | A1 Application with search report | No.: | EP1424997 | Date: | 09.06.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.03.2003 takes the place of the publication of the European patent application. | [2004/24] | Type: | B1 Patent specification | No.: | EP1424997 | Date: | 21.11.2007 | Language: | EN | [2007/47] | Search report(s) | International search report - published on: | US | 27.03.2003 | (Supplementary) European search report - dispatched on: | EP | 15.03.2006 | Classification | IPC: | A61K9/20, A61K47/00 | [2004/24] | CPC: |
A61K9/2077 (EP);
A61K9/1617 (EP);
A61K9/1652 (EP);
A61K9/205 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2004/24] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | AMINOSÄURE-MODULIERTE DOSIERFORM MIT VERLÄNGERTER FREISETZUNG | [2004/24] | English: | AMINO ACID MODULATED EXTENDED RELEASE DOSAGE FORM | [2004/24] | French: | FORME POSOLOGIQUE AMINOACIDIQUE À LIBERATION PROLONGÉE | [2007/18] |
| Former [2004/24] | FORME POSOLOGIQUE A ADMINISTRATION ORALE DE TYPE COMPRIME A LIBERATION MODIFIEE | Entry into regional phase | 18.03.2004 | National basic fee paid | 18.03.2004 | Search fee paid | 18.03.2004 | Designation fee(s) paid | 18.03.2004 | Examination fee paid | Examination procedure | 11.04.2003 | Request for preliminary examination filed International Preliminary Examining Authority: US | 18.03.2004 | Examination requested [2004/24] | 05.10.2006 | Despatch of a communication from the examining division (Time limit: M04) | 05.02.2007 | Reply to a communication from the examining division | 13.04.2007 | Communication of intention to grant the patent | 08.08.2007 | Fee for grant paid | 08.08.2007 | Fee for publishing/printing paid | Opposition(s) | 22.08.2008 | No opposition filed within time limit [2008/44] | Fees paid | Renewal fee | 18.03.2004 | Renewal fee patent year 03 | 04.02.2005 | Renewal fee patent year 04 | 06.02.2006 | Renewal fee patent year 05 | 05.02.2007 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP0311582 (HAESSLE AB [SE]) [A] * example 2; claim - *; | [A]US4866046 (AMER MOH S [US]) [A] * example 3 *; | [A]WO9748383 (JANSSEN PHARMACEUTICA NV [BE], et al) [A] * claim - *; | [A]US5811388 (FRIEND DAVID R [US], et al) [A] * abstract * | International search | [Y]WO9921551 (UNIV TEMPLE [US]); | [Y]US4675339 (INOUE YOSHIMI [JP], et al) | [Y] - ROHDEWALD, "The effect on the water solubility of several drugs by electrolytes. Part 4. amino acids", CAPLUS, Database accession no. 1978:412044, DN 89:12044, XP002950311 | [ ] - PHARM. ZTG., (1978), vol. 123, no. 9, pages 371 - 375 | [Y] - WATANABE ET AL., "Solubilization effects of L proline on slightly water-soluble drugs", BIOSIS, Database accession no. 1991:162706, DN: BA91:88506, XP002950312 | [ ] - YAKUZAIGAKU, (1990), vol. 50, no. 4, pages 397 - 401 |